![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.Total search results: 4730 | Ordered by Person (ascending)
1 2 3 ... 46 47 48 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Abate, Emmanuel (Danaher 202210 President Genomic Medicine at Cytiva) | President/Director/Head Business Group/Unit/Division | Danaher (Group) | South East England (region) |
| Abbott, Rachel (Pan Cancer T 202305– CEO joined as CSO 1/23 before Enara Bio + Adaptimmune) | Chief Executive Officer (CEO) | Pan Cancer T B.V. | South Holland (province, NL) |
| Abbott, Raymond (Albany Ventures) | n. a. | Albany Ventures (Group) | Scotland |
| Abecassis, William (BlackRock 202103 Head of Innovation Capital) | Investment Manager | BlackRock (Group) | United States (USA)_o |
| Abery, Julian (BioCity (GB) 201909– Director Business Development North America at BioAscent Discovery) | Business Development Manager / Strategy Manager | We are Pioneer Group (WAPG) (Group) | Scotland |
| Abribat, Thierry (Alizé Pharma 2007– President + Founder) | Chief Executive Officer (CEO) | Alizé Pharma (Group) | Auvergne-Rhône-Alpes (region) |
| Abu-Rabie, Paul (GSK 201010 Principal Scientist Bioanalytical Science & Development GSK R&D UK) | Researcher (industry) | GSK (Group) | East of England (region) |
| Acton, Gary (Antisoma 200604– CMO) | n. a. | Sarossa Capital (Group) | Greater London (region) |
| Adair, Fiona (Haptogen 200507– before Biovation + CXR Biosciences) | n. a. | Pfizer (Group) | Scotland |
| Adamis, Anthony P. (Jerini Ophthalmic 200703– CEO) | Chief Executive Officer (CEO) | Takeda (Group) | United States (USA)_o |
| Adams, Adrian (Auxilium 201112– CEO before Neurologix + Inspire Pharma + Sepracor + Kos + Novartis UK) | Chief Executive Officer (CEO) | Dainippon Sumitomo (Group) | Massachusetts (federal state) |
| Adams, Nicholas (Clavis Pharma 201107– CBO before Antisoma since 1999 BusDev Director + Manager + Ciba-Geiga + Eisai) | Chief Business Officer (CBO) | Aqualis ASA | Østlandet (Eastern Norway) (region) |
| Adelman, Burt (Dyax 2012–2016 EVP + CMO before Eleven Biotherapeutics + Biogen) | Board member, non-executive | Takeda (Group) | Massachusetts (federal state) |
| Adkins, John (Sterilin 200806 CEO) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | Wales |
| Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle) | Professor | ETH Zürich (ETHZ) | Zürich (region) |
| Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) | Chief Executive Officer (CEO) | Flagship Pioneering | Massachusetts (federal state) |
| Affara, Nabeel (Cambridge Univ Molecular Genetics Group 200211) | n. a. | University of Cambridge | East of England (region) |
| Afshar, Ali (Cytera Cellworks 202011 CEO + Co-Founder) | Chief Executive Officer (CEO) | Cytera CellWorks Ltd. | Greater London (region) |
| Agamirzian, Igor (Russia (govt) 201203 CEO of RVC Russian Venture Capital) | Chief Executive Officer (CEO) | Russia (govt) | Moskow (region) |
| Agazzi, Andrea (Lombardia (govt) 201604 President of NMS Group) | President/Director/Head Business Group/Unit/Division | NMS Group (Group) | Lombardia (Lombardy) |
| Aggarwal, Vijay (Aureon Laboratories 200410– before SKB + Quest Diagnostics) | n. a. | Aureon Laboratories Inc. | New York (federal state) |
| Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) | Managing Partner (investment firm) | Lundbeck (Group) | Hovedstaden |
| Ahmed, Nadim (BMS 202109 EVP) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | New York (federal state) |
| Ahmed, Omee (Alto Marketing 201512) | Public Relations Manager / Investor Relations Manager | Alto Marketing Ltd. | South East England (region) |
| Ahrens, Brent (Canaan Partners 201603 General Partner) | General Partner (venture partner) | Canaan Partners (Group) | California (federal state) |
| Ahrent, Esther (Olympus Life + Material Science Europa GmbH 200704 Section Manager Marketing Comm Microscopy) | n. a. | Olympus (Group) | Hamburg (federal state) |
| Aithani, Lakshyaditya Singh (Laksh) (Charm Therapeutics 202206 CEO + Co-Founder before Braavos + Exscientia + genei) | Chief Executive Officer (CEO) | Charm Therapeutics Ltd. | Greater London (region) |
| Aitkenhead, Mark (Element Biosciences 202205– Chief Commercial Officer before at Thermo Fisher since 2003) | Chief Commercial Officer (CCO) | Element Biosciences Inc. | California (federal state) |
| Aitman, Tim (CSC/Imperial College London 200503) | Professor | United Kingdom (GB) (govt) | United Kingdom (state/region unspecified) |
| Alanine, Alexander (Bactevo 201704– COO before Roche) | Chief Operating Officer (COO) | Astellas (Group) | East of England (region) |
| Alavijeh, Mohammad (Pharmidex 200602 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Pharmidex Pharmaceutical Services Ltd. | Greater London (region) |
| Alberici, Gilles (Orega Biotech 201601 CEO before Octalfa 2009 President before OPi SA founder + president) | Chief Executive Officer (CEO) | Orega Biotech (FR) | Auvergne-Rhône-Alpes (region) |
| Albertella, Mark (Storm Therapeutics 201905– VP Translational Oncology before Medivir + Argenta + OSI Pharmaceuticals) | Research & Development Manager | Storm Therapeutics Ltd. | East of England (region) |
| Albrecht, Klaus-Dieter (Synexus 201303– Managing Director fo Synexus Germany) | Managing Director | Synexus (Group) | Sachsen (federal state) |
| Albrecht, Uwe (Mediconomics 201704 Managing Director) | Managing Director | Mediconomics GmbH | Niedersachsen (federal state) |
| Albright, Kristen (Prokarium 202010– promoted to COO) | Chief Operating Officer (COO) | Prokarium Ltd. | Greater London (region) |
| Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) | Chief Executive Officer (CEO) | Hookipa (Group) | Wien (state) |
| Alder, Matthias (Autolus 201707– CBO + General Counserl before Sucampp + Cytos Biotechnology + Micromet + Cooley LLP) | Chief Business Officer (CBO) | Autolus Therapeutics plc (Nasdaq: AUTL) | Greater London (region) |
| Aleksik, Jelena (PharmEnable 202012 CBO before GeneAdviser) | Chief Business Officer (CBO) | PharmEnable Ltd. | East of England (region) |
| Aleotti, Alberto Giovanni (Menarini 201210 Board Member of A. Menarini) | Board member | Menarini (Group) | Toscana (Tuscany) |
| Alexander, Robert (ZS Pharma 201511 CEO) | Chief Executive Officer (CEO) | AstraZeneca (Group) | Texas (federal state) |
| Alexandrova, Natalia (Ariadne Genomics 200605) | n. a. | Reed Elsevier (Group) | Maryland (federal state) |
| Ali, Iraj (Achilles Therapeutics 201812– CEO before Interim CEO + Syncona + McKinsey) | Chief Executive Officer (CEO) | Achilles Therapeutics (Group) | East of England (region) |
| Allan, Eva-Lotta (Immunocore 201305– CBO before Ablynx 200606– CBO before Vertex Pharmaceuticals) | Chief Business Officer (CBO) | Immunocore (Group) | South East England (region) |
| Allcroft, Louise (Complement Genomics 200902 CEO) | Chief Executive Officer (CEO) | Complement Genomics Ltd. | North East England (region) |
| Allen, Chris (Broughton Laboratories 2011– Managing Director joind as Co-Founder 2006 before Sciantec Analytical) | Managing Director | Broughton Laboratories (GB) | Yorkshire and the Humber (region) |
| Allen, Dave (GSK 201609 SVP KSG Pharma RnD) | n. a. | GSK (Group) | Greater London (region) |
| Allen, Debbie (Argen-X 201204 Senior Director Business Development) | Business Development Manager / Strategy Manager | Argenx (Argen-X) (Group) | North Brabant (province, NL) |
| Allen, Mark (Tripos 200508) | n. a. | Provid Pharmaceuticals (Group) | United Kingdom (state/region unspecified) |
| Allen, Peter (Celltech 1992–2004 CFO) | Board member, non-executive | UCB (Group) | United Kingdom (state/region unspecified) |
| Allenby, Gary (Aurelia Bioscience 202106 Co-Founder) | Company Founder | Charnwood Molecular (Group) | East Midlands (region) |
| Allin, Steve (Charnwood Molecular 202207– Board Advisor + Investor before 1998–202207 CEO + Co-Founder) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Charnwood Molecular (Group) | East Midlands (region) |
| Allinson, John (Icon plc 201011 VP Biomarker Lab Services) | n. a. | Icon plc (Group) | Ireland (cl4) |
| Allmaier, Günter (Vienna University of Techology 201104 Professor) | Professor | Vienna University of Technology (TU Wien) | Wien (state) |
| Allmond, David (Novacyt 202110 CEO before Amryt Pharma + Amgen + Celgene + Aegerion Pharmaceuticals) | Chief Executive Officer (CEO) | Novacyt (Group) | Île-de-France (region) |
| Allott, Stephen (Trinamo Ltd. 200708 Executive Chairman) | Board member, executive | Danaher (Group) | Greater London (region) |
| Alloueche, Ali (Affiris 201112– CBO before GSK Biologicals before Novartis Vaccines and Diagnostics) | Chief Business Officer (CBO) | Affiris AG | Wien (state) |
| Almasi, Barna (Imaging Service AG 200906 CTO) | Chief Technology/Technical Officer (CTO) | Imaging Service AG | Bayern (federal state) |
| Almeida, José E. (Covidien 201112 CEO) | Chief Executive Officer (CEO) | Covidien (Group) | Ireland (cl4) |
| Almond, Andrew (Imperagen 202208 CEO + Founder formerly Co-Founder of Conformetrix/C4X Discovery) | Chief Executive Officer (CEO) | Imperagen Ltd. | North West England (region) |
| Alpert, Amir (Immatics 202305 Director Technology Scouting + Development) | n. a. | Immatics (Group) | Baden-Württemberg (federal state) |
| Altieri, Richard M. (Rick) (Oxford Immunotec 201311 CFO) | Chief Financial Officer (CFO) | Oxford Immunotec (Group) | South East England (region) |
| Amado, Rafael G. (Allogene 201909– EVP RnD + CMO before Adaptimmune + GSK + Amgen + UCLA) | Chief Medical Officer (CMO) | Allogene Therapeutics Inc. (Nasdaq: ALLO) | California (federal state) |
| Amiel, Laurent (General Electric 201005 General Manager EMEA GE Healthcare Performance Solutions) | General Manager (management) | General Electric (Group) | South East England (region) |
| Amijee, Hozefa (Ubiquigent 202211– Head of Business Development before Cellesce + RxCelerate + Total Scientific) | Business Development Manager / Strategy Manager | Ubiquigent Ltd. | Scotland |
| Amin, Naseem (Arix Bioscience 202011 Executive Chairman) | Board member, executive | Arix Bioscience (Group) | Greater London (region) |
| Anacleto, Joe (Bruker 201312 VP of Market Development before AB SCIEX + Life Technologies) | Business Development Manager / Strategy Manager | Bruker (Group) | Massachusetts (federal state) |
| Ananth, Radhika (Accel 202101 Vice President) | Investment Manager | Accel (Group) | Karnataka |
| Andersen, Thomas (Nextera AS 201510 CEO) | Chief Executive Officer (CEO) | Nextera AS | Østlandet (Eastern Norway) (region) |
| Anderson (formerly Broder), Elizabeth (LianBio 202103 VP Communications + IR before MeiraGTx) | Public Relations Manager / Investor Relations Manager | LianBio | |
| Anderson, Diana (Univ Bradford 201408 Professor at Faculty of Life Sciences) | Professor | University of Bradford | Yorkshire and the Humber (region) |
| Anderson, Errik (Biomatics Capital 201811– Venture Partner + Alloy Therapeutics before Adimab + Compass Therapeutics) | Venture Partner | Biomatics Capital Partners (US) | Washington (federal state) |
| Anderson, Joe (Perceptive Bioscience 201603 CEO) | Chief Executive Officer (CEO) | Perceptive Bioscience Investments Ltd. | Greater London (region) |
| Anderson, Joe (Sofinnova Partners 2022 Partner before Arix Bioscience + Abingworth) | Investment Manager | Sofinnova (Group) | Île-de-France (region) |
| Anderson, N. Leigh (Plasma Proteome Institute 200808 + SCISCAPA Assay Technologies) | mass spectrometry (MS) | Plasma Proteome Institute (PPI) | District of Columbia (federal state) |
| Anderson, Richard (Sciad Communications Co-founder before Bell-Pottinger + Founder of De Facto ) | Managing Partner | Sciad Communications Ltd. | Greater London (region) |
| Anderson, Thomas D. (Tom) (SwanBio Therapeutics 202203 CEO) | Chief Executive Officer (CEO) | SwanBio Therapeutics Inc. | Pennsylvania (federal state) |
| Ando, Osamu (Shimadzu 201005 General Manager Analytical & Measuring Instruments Div) | General Manager (management) | Shimadzu (Group) | Kinki (region) |
| Andreotti, Lamberto (Bristol-Myers Squibb 200609 Pres) | n. a. | Bristol Myers Squibb (BMS) (Group) | New York (federal state) |
| Andresen, Thomas Lars (T-Cypher Bio 202108– CEO before Torque Therapeutics + Monta Biosciences + Nanovi) | Chief Executive Officer (CEO) | T-Cypher Bio Ltd. | South East England (region) |
| Andrews, Ron A. (Ronnie) (Life Technologies 201202– President Medical Sciences before GE Healthcare + CEO of Clarient) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | California (federal state) |
| Andrikopoulos, Konstantinos (RXi Pharma 200811– VP Legal Counsel before Shire) | Legal Manager | Galena BioPharma Inc. | Massachusetts (federal state) |
| Angelici, Bruno (AstraZeneca 200812 Executive VP Intern Sales + Marketing) | Sales Manager / Marketing Manager | AstraZeneca (Group) | East of England (region) |
| Annable, Mike (Lab21 201202 Director Clinical Lab division) | Laboratory Manager (industry) | Novacyt (Group) | South East England (region) |
| Anninga, Bauke (Merck (DE) 202210 Principal at M Ventures) | Principal (venture capital) | Merck (DE) (Group) | North Holland (province, NL) |
| Ansari, Abid (Artios Pharma 202101– CFO before Precision BioSciences + GSK + MedImmune) | Chief Financial Officer (CFO) | Artios Pharma Ltd. | East of England (region) |
| Anson, John (Oxford Gene Technology 200601–202203 before Amersham Biosciences/GE Healthcare RETIRED 4/22) | Chief Executive Officer (CEO) | Sysmex (Group) | South East England (region) |
| Anson, Lisa (Redx Pharma 201806– CEO before AstraZeneca since 1998 before Salick Health Care + KPMG) | Chief Executive Officer (CEO) | Redx Pharma (Group) | North West England (region) |
| Anstey, Michael (Cambridge Innovaton Capital 201706 Investment Director) | Investment Manager | Cambridge Innovation Capital (Group) | East of England (region) |
| Antener, Mathias (Creoptix 202201 Head of Marketing) | Public Relations Manager / Investor Relations Manager | Spectris (Group) | Zürich (region) |
| Anthony, Daniel (Univ Oxford 201703 Prof at Dept of Pharmacology + Head of Experimental Neuropathology Lab) | Professor | University of Oxford | South East England (region) |
| Antoine, Lysta N. (Global Food Safety Partnership 201709 CEO) | Chief Executive Officer (CEO) | Global Food Safety Partnership (GFSP) | |
| Aoki, Naomi (Freeline Therapeutics 202302 SVP Head of IR + Corporate Communications) | Public Relations Manager / Investor Relations Manager | Freeline Therapeutics Holdings plc (FRLN) | East of England (region) |
| Apic, Gordana (Elpis BioMed 201711) | management (personnel) | Bit Bio Ltd. (bit.bio) | East of England (region) |
| Apicerno, Ken (Thermo Fisher 201003 Investor Relations) | Public Relations Manager / Investor Relations Manager | Thermo Fisher (Group) | Massachusetts (federal state) |
| Appleyard Ley, Zoe (Mulier Capital 200506) | n. a. | Mulier Capital Ltd. | Greater London (region) |
| Apweiler, R. | n. a. | EMBL (European Molecular Biology Laboratory) | East of England (region) |
| Araya, Arturo (TrakCel 202105– CCO based in US before Brainstorm Cell Therapeutics + Novartis + BMS) | Chief Commercial Officer (CCO) | TrakCel (Group) | New Jersey (federal state) |
| Archer, Richard (Automation Partnership 200001 CEO) | Chief Executive Officer (CEO) | Sartorius (Group) | East of England (region) |
| Arciero, Michael (ERS Genomics 202009– VP IP + Commercial Development before USC Stevents Center for Innovation) | IP Manager | University of Southern California (USC) | California (federal state) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
